Correlation Between Addex Therapeutics and Basilea Pharmaceutica

Can any of the company-specific risk be diversified away by investing in both Addex Therapeutics and Basilea Pharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Addex Therapeutics and Basilea Pharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Addex Therapeutics and Basilea Pharmaceutica AG, you can compare the effects of market volatilities on Addex Therapeutics and Basilea Pharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Addex Therapeutics with a short position of Basilea Pharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Addex Therapeutics and Basilea Pharmaceutica.

Diversification Opportunities for Addex Therapeutics and Basilea Pharmaceutica

0.1

Correlation Coefficient

Addex Therapeutics  Basilea Pharmaceutica

Average diversification

The 3 months correlation between Addex and Basilea is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Addex Therapeutics and Basilea Pharmaceutica AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Basilea Pharmaceutica and Addex Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Addex Therapeutics are associated (or correlated) with Basilea Pharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Basilea Pharmaceutica has no effect on the direction of Addex Therapeutics i.e., Addex Therapeutics and Basilea Pharmaceutica go up and down completely randomly.

Pair Corralation between Addex Therapeutics and Basilea Pharmaceutica

Assuming the 90 days trading horizon Addex Therapeutics is expected to generate 18.33 times less return on investment than Basilea Pharmaceutica. In addition to that, Addex Therapeutics is 1.62 times more volatile than Basilea Pharmaceutica AG. It trades about 0.01 of its total potential returns per unit of risk. Basilea Pharmaceutica AG is currently generating about 0.24 per unit of volatility. If you would invest  4,405  in Basilea Pharmaceutica AG on May 5, 2025 and sell it today you would earn a total of  1,395  from holding Basilea Pharmaceutica AG or generate 31.67% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Addex Therapeutics  vs.  Basilea Pharmaceutica AG

Addex Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Addex Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Addex Therapeutics is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Basilea Pharmaceutica

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Basilea Pharmaceutica AG are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Basilea Pharmaceutica showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Addex Therapeutics and Basilea Pharmaceutica

The main advantage of trading using opposite Addex Therapeutics and Basilea Pharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Addex Therapeutics position performs unexpectedly, Basilea Pharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Basilea Pharmaceutica will offset losses from the drop in Basilea Pharmaceutica's long position.

The idea behind Addex Therapeutics and Basilea Pharmaceutica AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.